Richard Mckilligan - Dec 10, 2021 Form 4 Insider Report for MALACHITE INNOVATIONS, INC. (MLCT)

Role
Chief Financial Officer
Signature
/s/ Richard McKilligan
Stock symbol
MLCT
Transactions as of
Dec 10, 2021
Transactions value $
$0
Form type
4
Date filed
12/13/2021, 08:00 AM
Next filing
Mar 31, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -10K -100% $0.00* 0 Dec 10, 2021 Common Stock 10K $2.70 Direct F1, F5
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -20K -100% $0.00* 0 Dec 10, 2021 Common Stock 20K $3.40 Direct F2, F5
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -20K -100% $0.00* 0 Dec 10, 2021 Common Stock 20K $2.10 Direct F3, F5
transaction MLCT Stock Option (Right to Buy) Disposed to Issuer $0 -75K -100% $0.00* 0 Dec 10, 2021 Common Stock 75K $1.81 Direct F4, F5
transaction MLCT Stock Option (Right to Buy) Award $0 +115K $0.00 115K Dec 10, 2021 Common Stock 115K $0.28 Direct F5
transaction MLCT Stock Option (Right to Buy) Award $0 +35.2K +30.7% $0.00 150K Dec 10, 2021 Common Stock 35.2K $0.28 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 An option to purchase 10,000 shares of common stock was granted to the Reporting Person on 8/6/12, 3,333 shares vested on 1/1/13 and 1/1/14, and 3,334 shares vested on 1/1/15.
F2 The option provided for vesting in four equal semi-annual installments beginning on 7/1/15.
F3 The option provided for vesting in four equal semi-annual installments beginning on 11/21/15.
F4 The option provided for vesting in four equal semi-annual installments beginning on 6/27/18.
F5 On December 10, 2021, the issuer canceled, this option pursuant to the issuer's option exchange program, the options listed above. In exchange, the Reporting Person received a replacement option to purchase 114,769 shares at an exercise price of $0.277. This replacement option vested immediately.
F6 On December 10, 2021, the Reporting Person was granted options to purchase 35,231 shares of common stock at an exercise price of $0.277. This option vested immediately.